Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy

Inclusion Criteria: * Healthy non-smoking post menopausal women with absence of menstruation of at least 12 months * Exhibiting VVA symptoms * Prolapse staged \< II, according to the pelvic organ prolapse quantification (ICS-POP-Q) system * Have not had procedures in the anatomical area through 6 months prior to treatment * Understand and accept the obligation and is logistically able to present for all scheduled follow-up visits Exclusion Criteria: * • Acute or recurrent urinary tract infection (UTI), or genital infection (e.g. herpes candida). * Prolapse staged ≥ II, according to the pelvic organ prolapse quantification (ICS-POP-Q) system * Any serious disease, or chronic condition, that could interfere with the study compliance * Previously undergone reconstructive pelvic surgery * Have used vaginal creams, moisturizers, lubricants or homeopathic preparations for at least 3 months * A history of thrombophlebitis * A history of acute infections * A history of heart failure * Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics, vitamin E or anti inflammatories within 2 weeks pre treatment * Any medical condition, that, in the investigator's opinion would interfere with the patient's participation in the study * Taking medications that are photosensitive * A history of keloid formation